Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Clearly you know insiders and goings on within this company, can you elaborate to your relationship or history with the company??
Simply for my own credibility assignment.
Thanks in advance!
How many times has this thing reversed 5:1 and back down to $6 since its inception?
Goes to show you what crap vehicles these are on either side. Last time JNUG traded these levels JDST was near $90. Today $55 ish. Decay. Both sides lose. Scalp TA trades only.
And so what if gold has a massive rally. It would take 2012 levels to simply get back to even on the POS if you bought and held for last two years. Pure garbage.
That’s why there is a debate. People are questioning the information you are providing on a public forum. You have a very one sided view of this company but may have valid points that will be determined and proven true or not in the very near future. For my investment’s sake, I hope you are wrong. I’ll be doing some due diligence in the near future to substantiate some of your red flag claims. If proven, thanks for the heads up.
As it has always done. Same $hit...different day. This ETF is pure garbage unless you’re short. The flip side loses to decay too so neither is worth a look.
I agree with you on several fronts. This is a crap shoot. What I don’t agree with you on is that companies provide false data all the time. Analysts and insiders can and do pump to dump low float stocks often for their own gain. It beats bankruptcy and small companies can limp thru penny land exchanges for decades.
What is better for investors....
A creative financing plan or closing the doors. So, diluting an investor is clearly better than handing them a sorry note.
I made a crappy investment in a company that looked to have a solid growth strategy in a booming cannabis sector. It was a Long shot, but it was and is a real product with, what at the time, I thought to be a top of the line model needed in growing market.
Volume is dreadful. Spread sucks. Nothing good to report. Time will tell. But to say the employees are all working for free food, happy hour drinks, and 4 hour vape breaks, sounds far more ludicrous than a company coming up with a creative funding plan to further their business operation. Time will tell.
I’ll have to agree. A newly listed company can simply dilute to raise cash with an imaginary prospectus if they really needed to.
I’ll ride this for a bit and seen what the next Q looks like. Hopefully they issue some forward looking marketing and growth plans prior.
Cheers. My hat is already in and severely underwater.
Maybe I’ll give the company a call one of these days, go thru the company directory, and see if anyone answers.
Maybe he’s a former disgruntled employee. His attacks seem personal and knowledge of on-goings throughout the company, office behaviors and payroll shortfalls, seem privy.
That or it’s conjecture and pure lies.
That is the problem. Or eliminate hierarchy compensations when they control the vote.
Seriously!? How do you know they missed payroll?
R u being serious....What happened to the big international expansion plans with financial backers??
You just like saying “boner”.
Yet the stock is stuck in the mud with dead volume. The street hates this stock for whatever reason.
What will it take? Profitability? Sell off the MLM division, downsize, eliminate revenue draining personnel and compensations? Refocus on growth and revenues of coffee and hemp? Grow organically with efficiency and final show a positive bottom line?
Lol. It’s always next week. Just like my favorite pub has a sign hanging behind the bar....”Free Beer Tomorrow”. Tomorrow never comes.
Seems redundant. But then again that’s JNUG to a tee. JNUG is the epitome of redundancy.
You are correct. Cash don’t last long in the bio bank. And then expect more misery once FDA approval nears. Look at HRTX today. The dreaded letter. A letter similar cost me hundreds of thousands of dollars on a slam dunk. Now worth pennies.
That’s what I was saying. They are good for now. Trials eat up millions quickly. This seems like a highly undervalued stock based on the pipeline and available cash. The street doesn’t it see it that way. Institutional holdings are always a good sign. GLTY
Volume is dead. Retail has left the building. With bio’s it’s always about pr’s, pipeline development, and timelines. Their pipeline is decent. Next run will come I’m sure, but hopefully before the need for cash and dilution.
Thanks. You too!
I’m out. Wed to Fri 2k gainer is good enough for me. Weekend beers will taste better with gains locked in.
Who doesn’t love a long legged doji!
WB, would you consider holding thru the weekend or will you cut bait and look towards a technical reset next week?
Thanks man, you have a great weekend!
Looks like someone else is dumping shares at $2 here.
I get it. Still holding a large chunk way under water in juniors.
Picked up mid to upper 15’s here midweek to swing. Looking like a good exit here as momo is stalling.
Just curious if your charts see something above.
Is there another leg left here today?
Holding or dumping....what say you chartists?
Brutal. These ETF’s are terrible. November ‘18 when JNUG was at these levels JDST was trading in the 70’s to low 80’s. Today upper 40’s. Convergent decay. Junk on either side unless of course you’re day trading it, which is the obvious way to go. Trapped and held like a fool is where I’m at.
Perception of morality is a joke. That is a non issue. This is a mainstream movement. Other than a legislative timing issue, that article speaks to nothing. A mass population of users and uses exist once regulatory obstacles clear. There simply are too many companies with their toes in this pool. Over time only a small fraction will survive as growers and distributors. R & D costs and efficiency in production will determine profitability. UF agriculture concerns are a joke. Pharma dispensary concerns, another joke.
On the retail side, look around, there are a zillion ways to make money from hemp to table. Exponential Consumer dollars are at stake. It’s all about development and marketing. The question here is, does YGYI have a viable plan, with collaboration agreements, and ability to execute. I would say yes. Their opportunities to grow sales and become profitable as a result of their involvement in this space seem better than ever, providing greed takes a back seat. The MLM model allows for constant compensations and has been an anchor to the company’s bottom line for years. Ygyi’s cost of growth has also being outweighing the bottom line benefit. At some point that has to change and they’ll have to grow the company organically. Finding ways to grow their Coffee and cannabis segments clearly can be a road to profitability.
I semi agree with that.
However, consistent low dosing amounts throughout a day may have similar effects as taking 10 drops sublingually once a day. A benefit is a benefit. As I mentioned before, as an additive, it should be less regulated. As an efficacy dosing it will be more heavily scrutinized at a regulatory level. Who knows. Gimmick ish. I use it in concentrated drop form. It works for me. In a coffee caffeine transport system at lower dosing, maybe it still has a similar effect. If you drink it throughout the day in various forms and beverages, I’m sure it will have a benefit similar to glucosamine or other supplemental ingredients. That is how this CBD integration should be viewed. medicinal dosing thru a water beverage isn’t the marketing plan imo.
Look out below. Saw it coming but not in a blink. Damn. Zero support.
Under 8 is a probability not a possibility. Then bounce back to 9.25
It’s good to see some volume here tho. Hopefully that continues and we build a strong base.
So you’re saying there’s a chance?!
Can it not still be used as an off indication ingredient until the FDA clears it for medical benefit or supplemental use? Simply because the FDA doesn’t identify it as such, doesn’t mean there isn’t an ability to include it as an ingredient or be used in a beverage as a benefit to some. No different than saying kombucha is a digestive aid.
My concern would be that it wouldn’t be allowed in as an ingredient period. Does CBD need FDA approval as a simple ingredient or additive?
Ur welcome man. I learned a hard lesson a decade ago.
Even the best looking drug candidates are susceptible to this business model. Even, if all goes well in clinical studies, the FDA holds all the cards. One in a million of these small biotechs can get you rich....good luck finding it. In the mean time, they can be good swing trade vehicles if you can time the PR’s well. Chase the volume. GLTY.
Biotech reality. Look at ADXS. PR positive clinical. Drive the share price. Soon after, dilution. Rinse. Repeat. Don’t think SEEL wouldn’t do the same. Ive seen it too many times with small and mid cap biotech. The cash only lasts so long and these companies have no revenue stream.
Huge news! As I said, coffee and CBD futures contracts are rocket fuel for this stock. More to come hopefully. Let’s see some volume today.
Regardless. Thanks for info. I’m always looking.